Deeper Insights for New Discoveries

SonoVanta™ is a safe, near-infrared contrast agent platform engineered to transform Photoacoustic Imaging — enabling targeted deep-tissue imaging and sensing for pre-clinical research.

Diagram of NIR-Photoacoustics imaging, showing an 895 nm NIR laser targeting ICG J-aggregates in tissue, generating photoacoustic signals. The signals are captured by a computer to create a deep tissue PA image of the tumor.

The Problem: Photoacoustic Imaging (PAI)

  • A non-invasive and cost-effective imaging modality used in many preclinical studies

  • Offers high contrast and high spatial resolution to provide anatomical and functional information

Limitations of Current Contrast Agents

Commercially available PAI contrast agents are limited by several critical issues:

  • Poor safety profile

  • Low photostability

  • Limited depth of imaging

  • Poor solubility

  • Limited targeting

An advertisement for ICG Aggregates, a product used for high-contrast photoacoustic imaging. It features a digital rendering of a green nanoparticle with several labels including "ICG J-AGGREGATE (NANOPARTICLE)," "895 nm NIR ABSORPTION PEAK," and a depiction of a laser beam hitting tissue, producing a photoacoustic image of blood vessels.

Our Solution: SonoVanta™

  • Safe — ICG-based platform (ICG is FDA approved)

  • Versatile — size tunable to cross biological barriers

  • Robust, cost effective & scalable — self-assembly production process

  • Compatible with major commercial instruments

  • Strong photoacoustic signal (no fluorescence) and photostable

  • Sharp NIR absorption peak at 895 nm wavelength for deep imaging

  • Targeted to improve specificity and limit off-target effects

Who We Serve

Academic Researchers

Access a versatile, near-infrared contrast agent platform purpose-built for pre-clinical PAI studies in diagnostic imaging, therapeutic efficacy, and drug biodistribution.

Pharmaceutical Companies

Accelerate drug development pipelines with precise, deep-tissue imaging data powered by SonoVanta™ — enabling clearer biodistribution and efficacy insights.

Technology Partners

Collaborate with NanOptical Biomedical to integrate SonoVanta™ into next-generation imaging systems and expand the frontier of photoacoustic applications.